The Kappa/Lambda ratio shows the balance between the free light chains
The Kappa/Lambda ratio is not a separate substance in the blood but a calculated ratio between S-FLC Kappa and S-FLC Lambda. The ratio is used to assess whether the production of free immunoglobulin light chains is balanced or whether one type clearly dominates over the other.
This is important because a high value of kappa or lambda is not always pathological in itself. For example, both chains can rise simultaneously in cases of impaired kidney function or general activation of the immune system. The ratio helps to show whether the increase is still proportional or whether there is a clear skewed distribution.
What can the ratio provide diagnostically?
During normal antibody production, plasma cells produce both kappa and lambda chains in a relatively stable ratio. If an individual plasma cell clone begins to produce large amounts of only one type of light chain, the balance can be upset. It is this change that the Kappa/Lambda ratio is intended to capture.
The ratio is therefore used primarily as part of the investigation and follow-up of monoclonal gammopathies and plasma cell diseases, such as MGUS, multiple myeloma, light chain myeloma and AL amyloidosis. It can also provide important supplementary information when serum electrophoresis or other protein analyses show a clear M component.
How to interpret different FLC patterns
It is the combination of the ratio and the absolute levels of kappa and lambda that is most informative. Some typical interpretation patterns are:
- Elevated kappa and high ratio – may indicate a kappa-dominated monoclonal production.
- Elevated lambda and low ratio – may indicate a lambda-dominated monoclonal production.
- Elevated kappa and lambda with relatively preserved ratio – may be seen in polyclonal immune activation or impaired renal function.
- Normal ratio – reduces the suspicion of a pronounced imbalance between kappa and lambda, but does not exclude all monoclonal conditions.
It is therefore inappropriate to interpret the ratio in isolation. A numerical ratio value always needs to be put in relation to the two components on which the ratio is based.
What does a high or low Kappa/Lambda ratio mean?
Elevated ratioAn elevated Kappa/Lambda ratio means that kappa occurs in a higher proportion than lambda. If S-FLC Kappa is also elevated, the finding may indicate a kappa-dominated clonal plasma cell production. How significant the finding is depends on the degree of deviation and on other laboratory and clinical findings.
Reduced ratioA lowered Kappa/Lambda ratio means that lambda dominates in relation to kappa. If S-FLC Lambda is also elevated, this may indicate a lambda-dominated monoclonal production.
Neither a high nor a low ratio is in itself diagnostic for myeloma or other malignant disease. The ratio serves as a signal that the balance between the free light chains is altered and that the result may need to be investigated further.
Reference interval and calculation
The Kappa/Lambda ratio is calculated by dividing the concentration of S-FLC Kappa by the concentration of S-FLC Lambda. The ratio is therefore unitless. For the current analysis method, the reference interval is 0.31–1.56. The reference interval is method-dependent and the interval specified in the current laboratory result should be used for interpretation.
The importance of the kidneys in interpretation
Free light chains are eliminated mainly via the kidneys. When kidney function deteriorates, the concentrations of both kappa and lambda can rise. Therefore, a person with impaired kidney function can have clearly elevated FLC levels without this being due to a monoclonal plasma cell disease.
The Kappa/Lambda ratio itself can also be affected by kidney function impairment. Creatinine and eGFR are therefore important in the assessment, and laboratories may use specific interpretation limits in certain kidney-related contexts.
Why is the ratio monitored over time?
In people with an already known monoclonal gammopathy, changes in FLC levels and the Kappa/Lambda ratio can provide information during follow-up. A ratio that changes together with the involved free light chain may reflect altered plasma cell activity.
When following up, it is important to compare results from the same or comparable analysis method, as different laboratory methods may give slightly different results and reference intervals.
The ratio is part of an overall FLC assessment
In the blood sample Free immunoglobulin chains (FLC), S-FLC Kappa and S-FLC Lambda are analyzed, after which the Kappa/Lambda ratio is calculated. The three results should be seen as a coherent analysis rather than three independent findings.
If monoclonal gammopathy is suspected, the FLC results can be supplemented with serum protein fractions or serum eluphoresis, immunofixation, immunoglobulins, blood count, renal function tests and calcium. Which additional tests are needed depends on the clinical question.
Important for interpretation
The Kappa/Lambda ratio is primarily a marker for the distribution between free kappa and lambda chains. A deviating result can strengthen the suspicion of monoclonal light chain production, but cannot alone determine the cause.
The medical significance is determined by how much the ratio deviates, which of the free light chains is elevated, renal function and other laboratory and clinical findings.
